Form 4: CorMedix CEO Joseph Todisco Reports Stock Disposal
SEC Form 4 Filing
Joseph Todisco, CEO of CorMedix Inc., disposed of 26,982 shares of common stock on May 10, 2024, to cover tax obligations.
Summary
- On May 10, 2024, Joseph Todisco, the CEO of CorMedix Inc., disposed of 26,982 shares of common stock.
- The transaction was executed at a price of $5.17 per share.
- Following the transaction, Todisco directly owns 325,857 shares of CorMedix Inc.
- The disposal was related to tax obligations.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a standard transaction (disposal of shares for tax obligations) by an insider, which is a common occurrence.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in trading activities by company insiders. This allows the market to be informed about the actions of key personnel.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the disposal.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Date of stock disposal transaction |
| 05/13/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.